DENTSPLY SIRONA INC (XRAY) Stock Earnings Estimates

NASDAQ:XRAY • US24906P1093

14.68 USD
+1.97 (+15.5%)
At close: Feb 27, 2026
14.79 USD
+0.11 (+0.75%)
After Hours: 2/27/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
XRAY revenue by date.XRAY revenue by date.
3.965B
1.10%
3.793B
-4.34%
3.68B
-2.98%
3.74B
1.63%
3.833B
2.49%
3.97B
3.57%
4.094B
3.12%
EBITDA
YoY % growth
XRAY ebitda by date.XRAY ebitda by date.
639M
-7.66%
579M
-9.39%
605M
4.49%
648.76M
7.23%
695.1M
7.14%
778.09M
11.94%
836.4M
7.49%
EBIT
YoY % growth
XRAY ebit by date.XRAY ebit by date.
296M
-18.68%
230M
-22.30%
253M
10.00%
496.65M
96.30%
531.84M
7.09%
604.1M
13.59%
N/A
Operating Margin
XRAY operating margin by date.XRAY operating margin by date.
7.47%6.06%6.88%13.28%13.88%15.22%N/A
EPS
YoY % growth
XRAY eps by date.XRAY eps by date.
1.83
-12.02%
1.67
-8.74%
1.59
-4.79%
1.56
-2.08%
1.76
13.12%
2.02
14.82%
2.07
2.14%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.37
-14.41%
0.47
-8.68%
0.40
7.94%
0.40
46.61%
0.44
19.87%
0.49
4.18%
0.40
0.25%
0.43
7.58%
Revenue
Q2Q % growth
912.7M
3.83%
959.1M
2.47%
931.23M
3.01%
959.99M
-0.11%
938.05M
2.78%
985.64M
2.77%
947.16M
1.71%
982.58M
2.35%
EBITDA
Q2Q % growth
149.78M
-1.46%
184.24M
-33.73%
158.36M
-48.58%
164.39M
-55.81%
181.04M
20.87%
197.49M
7.19%
161.57M
2.03%
177.05M
7.70%
EBIT
Q2Q % growth
114.27M
56.53%
149.2M
34.41%
127.03M
159.24%
133.64M
568.20%
145.75M
27.55%
158.87M
6.48%
126.83M
-0.16%
140.22M
4.92%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
0.27
3.85%
0.28-0.01-4.78%
Q3 2025
Q2Q % growth
0.37
-26.00%
0.46-0.09-19.03%
Q2 2025
Q2Q % growth
0.52
6.12%
0.510.011.49%
Q1 2025
Q2Q % growth
0.43
2.38%
0.300.1345.37%
Q4 2024
Q2Q % growth
0.26
-40.91%
0.44-0.18-40.52%
Q3 2024
Q2Q % growth
0.50
2.04%
0.480.024.59%
Q2 2024
Q2Q % growth
0.49
-3.92%
0.51-0.02-3.31%
Q1 2024
Q2Q % growth
0.42
7.69%
0.43-0.01-1.58%
Q4 2023
Q2Q % growth
0.44
-4.35%
0.440.00-0.45%
Q3 2023
Q2Q % growth
0.49
19.51%
0.490.00-0.67%
Q2 2023
Q2Q % growth
0.51
-26.09%
0.440.0716.28%
Q1 2023
Q2Q % growth
0.39
-25.00%
0.350.0412.73%
Q4 2022
Q2Q % growth
0.46
-39.47%
0.330.1340.20%
Q3 2022
Q2Q % growth
0.41
-39.71%
0.58-0.17-29.60%
Q2 2022
Q2Q % growth
0.69
-2.82%
0.570.1220.02%
Q1 2022
Q2Q % growth
0.52
-27.78%
0.57-0.05-8.36%
Q4 2021
Q2Q % growth
0.76
-12.64%
0.80-0.04-5.30%
Q3 2021
Q2Q % growth
0.68
1.49%
0.660.022.42%
Q2 2021
Q2Q % growth
0.71
494.44%
0.660.057.14%
Q1 2021
Q2Q % growth
0.72
67.44%
0.570.1525.70%
Q4 2020
Q2Q % growth
0.87 0.650.2233.11%
Q3 2020
Q2Q % growth
0.67 0.320.35106.78%
Q2 2020
Q2Q % growth
-0.18 -0.02-0.16-629.22%
Q1 2020
Q2Q % growth
0.43 0.390.049.42%
XRAY Yearly EPS VS EstimatesXRAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
961M
6.19%
945.62M15.38M1.63%
Q3 2025
Q2Q % growth
904M
-4.94%
914.64M-10.64M-1.16%
Q2 2025
Q2Q % growth
936M
-4.88%
951.93M-15.93M-1.67%
Q1 2025
Q2Q % growth
879M
-7.76%
872.3M6.7M0.77%
Q4 2024
Q2Q % growth
905M
-10.57%
938.97M-33.97M-3.62%
Q3 2024
Q2Q % growth
951M
0.42%
957.88M-6.88M-0.72%
Q2 2024
Q2Q % growth
984M
-4.28%
1.015B-31M-3.05%
Q1 2024
Q2Q % growth
953M
-2.56%
988.52M-35.52M-3.59%
Q4 2023
Q2Q % growth
1.012B
2.95%
996.4M15.6M1.57%
Q3 2023
Q2Q % growth
947M 994.71M-47.71M-4.80%
Q2 2023
Q2Q % growth
1.028B
0.49%
1.019B9M0.88%
Q1 2023
Q2Q % growth
978M
0.93%
956.45M21.55M2.25%
Q4 2022
Q2Q % growth
983M
-7.96%
960.19M22.81M2.38%
Q3 2022
Q2Q % growth
947M
-8.94%
1.047B-100M-9.55%
Q2 2022
Q2Q % growth
1.023B
-3.67%
1.032B-9M-0.87%
Q1 2022
Q2Q % growth
969M
-5.56%
1.008B-39M-3.87%
Q4 2021
Q2Q % growth
1.068B
-1.05%
1.152B-84M-7.29%
Q3 2021
Q2Q % growth
1.04B
16.23%
1.046B-6M-0.57%
Q2 2021
Q2Q % growth
1.062B
116.47%
1.033B29M2.81%
Q1 2021
Q2Q % growth
1.026B
17.35%
967.68M58.32M6.03%
Q4 2020
Q2Q % growth
1.079B 1.016B63.3M6.23%
Q3 2020
Q2Q % growth
894.8M 855.8M39M4.56%
Q2 2020
Q2Q % growth
490.6M 502.4M-11.8M-2.35%
Q1 2020
Q2Q % growth
874.3M 891.03M-16.73M-1.88%
XRAY Yearly Revenue VS EstimatesXRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.23% -0.71% -0.07% -14.61%
Revenue-0.04% 0.06% -0.03% -0.24%